Billing Under the Illinois Fertility Mandate: BCBS IL Auth, Cycle Tracking, and ICSI/PGT Requirements

Illinois' fertility insurance mandate, 215 ILCS 5/356m, was broadened again by P.A. 103-751 for group policies issued or renewed on or after January 1, 2026. For fertility practices serving patients on Illinois-regulated group health plans, mastering the mandate's exact requirements — and the billing protocols that flow from them — is the difference between capturing every dollar of legitimate reimbursement and losing revenue to preventable authorization failures and uncollectible claim denials.

This post covers the statutory foundation of the Illinois mandate, the full scope of covered services, applicable CPT and ICD-10 codes, carrier-specific prior authorization requirements, FET billing rules, and the most frequent coding and workflow errors that generate claim denials under Illinois-mandated plans.

The Statutory Foundation: 215 ILCS 5/356m

The Illinois fertility insurance mandate is codified in 215 ILCS 5/356m of the Illinois Insurance Code. The statute requires group accident and health insurance policies delivered or issued in Illinois to cover the diagnosis and treatment of infertility. The current text, as amended by P.A. 103-751 (effective August 2, 2024), splits coverage by policy date: subsection (a) governs group policies issued or renewed through December 31, 2025, and subsection (a-5) governs group policies issued or renewed on or after January 1, 2026. Both apply only to policies that provide pregnancy-related benefits.

For policies issued or renewed through December 31, 2025, the mandate applies to group policies covering more than 25 employees. For policies issued or renewed on or after January 1, 2026, subsection (a-5) has no employee threshold. Either way it reaches only fully insured plans, and the statute exempts policies issued to religious organizations whose teachings the procedures violate. Self-funded employer plans governed by ERISA are exempt from state insurance mandates by federal preemption. This is the single most consequential exclusion for billing staff to understand: misidentifying a self-funded plan as mandate-compliant is the leading source of uncollectible fertility claims in Illinois practices. Confirm plan funding type in writing before any cycle begins.

215 ILCS 5/356m(c) defines infertility as a disease, condition, or status characterized by any one of three things: (1) failure to establish a pregnancy or carry a pregnancy to live birth after 12 months of regular, unprotected intercourse if the woman is 35 or younger, or after 6 months if she is over 35 (a miscarriage does not restart the 12- or 6-month term); (2) a person's inability to reproduce, either as a single individual or with a partner, without medical intervention; or (3) a licensed physician's findings based on the patient's medical, sexual, and reproductive history, age, physical findings, or diagnostic testing. Prongs (2) and (3) are how same-sex couples and single patients qualify without a period of attempted conception. The statute does not require a therapeutic donor insemination (TDI) protocol or set a number of insemination cycles before IVF. For policies issued or renewed through December 31, 2025, subsection (b)(1) does condition IVF, GIFT, and ZIFT coverage on the patient having been unable to achieve or sustain a pregnancy through reasonable, less costly, medically appropriate treatments covered by the policy, and a carrier may point to that when it asks for prior insemination cycles. Subsection (a-5), for policies issued or renewed on or after January 1, 2026, contains no such condition. When a carrier asks for TDI cycles, ask which policy provision it is applying.

Covered Fertility Services Under the Illinois Mandate

The Illinois mandate requires coverage across the full spectrum of infertility diagnosis and treatment. Services that must be covered under compliant Illinois group plans include:

• Diagnostic infertility workup — labs (FSH, LH, estradiol, AMH, prolactin, thyroid panel), semen analysis (89310, 89320, 89322) and the post-coital (Huhner) test (89300), hysterosalpingography (HSG; CPT 74740), ovarian reserve testing including antral follicle count (76830), diagnostic hysteroscopy (58555), diagnostic laparoscopy (49320, 58660), and endometrial biopsy (58100)
• IUI (intrauterine insemination) — sperm preparation/wash (89260) and the insemination procedure (58322); most Illinois plans do not impose a hard IUI cycle cap under the mandate, though plan documents may specify limits
• IVF (in vitro fertilization) — complete fresh cycle including ovarian stimulation, ultrasound and hormonal monitoring, oocyte retrieval (58970 with 76948 for ultrasound guidance), embryo culture (89250), conventional insemination (89268), ICSI (89280 for ≤10 oocytes; 89281 for >10 oocytes), extended embryo culture (89272), and embryo transfer (58974)
• Embryo cryopreservation and frozen embryo transfer (FET) — embryo freezing (89258), embryo thaw (89352), and FET procedure (58974 or 58976); most Illinois fully insured plans cover FET cycles, though plan language on whether FETs count against the retrieval lifetime cap varies by carrier
• Embryo biopsy for PGT (preimplantation genetic testing) — 89290 (biopsy, ≤5 specimens) and 89291 (biopsy, >5 specimens); for policies issued or renewed on or after January 1, 2026, subsection (a-5) requires coverage of procedures to screen or diagnose a fertilized egg before implantation, including PGT-A, PGT-SR, and PGT-M; earlier policies were not required to cover PGT, so coverage there is carrier-specific; carriers may still require a separate PA
• Surgical sperm extraction — added to the required list by subsection (a-5) for policies issued or renewed on or after January 1, 2026; not on the list for earlier policies
• GIFT (gamete intrafallopian transfer) and ZIFT (zygote intrafallopian transfer) — covered under the mandate; rarely performed clinically today but included in the statutory coverage list
• Iatrogenic fertility preservation — egg cryopreservation (89337) before treatment that may cause infertility (chemotherapy, pelvic radiation, surgery) falls under a separate section, 215 ILCS 5/356z.32, which requires individual and group policies amended, delivered, issued, or renewed after January 1, 2019 to cover medically necessary standard fertility preservation services when a necessary medical treatment may directly or indirectly cause iatrogenic infertility; bill it with Z31.84 first-listed and the underlying (for example, oncology) diagnosis after it rather than infertility codes, and do not bill iatrogenic preservation with N97.x codes

The mandate does not require coverage for: elective (social) egg freezing in patients without a fertility-threatening medical diagnosis; gestational carrier fees paid to a third-party surrogate; sperm or egg donor acquisition or compensation fees (though monitoring and procedure costs for a donor recipient cycle are typically covered for the recipient patient); and procedures classified as experimental under the applicable carrier's fertility medical policy.

Benefit Limits and Lifetime Cycle Tracking

For policies issued or renewed through December 31, 2025, subsection (b) requires IVF, GIFT, and ZIFT coverage only after less costly treatments have not worked and only until the patient has had 4 completed oocyte retrievals, with 2 more if a live birth follows a completed retrieval. Subsection (a-5), which governs policies issued or renewed on or after January 1, 2026, has no retrieval limit; it instead requires that the procedure be medically appropriate under ASRM, ACOG, or SART guidelines and be performed at a SART member clinic. Subsection (d) bars deductibles, benefit maximums, and other limits on infertility diagnosis and treatment that differ from those on other services, except as the section provides. At initial patient eligibility verification, collect the following from the insurer in writing:

• The group policy's issue or most recent renewal date, which decides whether subsection (a) or (a-5) applies
• The total number of covered IVF retrieval cycles remaining in the patient's lifetime benefit and, if applicable, how many have already been used across all facilities
• For pre-2026 policies, whether the carrier counts FET cycles against the 4-retrieval limit or treats them as a distinct benefit
• Whether IUI cycles are capped and, if so, the number of covered cycles remaining
• Whether the plan applies any lifetime dollar maximum or cycle count to infertility services, and the plan language it relies on
• The plan's definition of a "completed" IVF cycle — specifically whether a cancelled stimulation cycle in which no egg retrieval was performed counts against the lifetime cap
• Whether PGT-A, PGT-M, or PGT-SR cycles require separate prior authorization distinct from the IVF retrieval authorization
• The specific prior authorization route and any utilization management vendor for fertility services (for BCBS IL, the Availity eligibility and benefits check identifies the vendor, if any)

CPT Code Reference for Illinois Mandate Fertility Services

ICD-10 Diagnosis Coding for Illinois Mandate Claims

Accurate ICD-10 coding determines whether a fertility claim routes to the mandate benefit or triggers medical necessity review. Carriers use the primary diagnosis code to validate mandate applicability. Non-specific or mismatched codes generate additional documentation requests that delay payment or result in denial.

Primary infertility diagnosis codes for Illinois mandate claims: N97.0 (female infertility associated with anovulation — use for PCOS, anovulatory cycles); N97.1 (female infertility of tubal origin — use for documented tubal factor, prior ectopic, tubal ligation reversal); N97.2 (female infertility of uterine origin — use for uterine anomaly, Asherman's syndrome, submucosal fibroid); N97.8 (female infertility of other or combined origin — appropriate for combined factor or when two distinct etiologies are present); N97.9 (female infertility, unspecified — use only when no etiology can be documented; avoid as primary code when any etiology is available, as it is the weakest code for medical necessity defense). Male factor codes: N46.01 (organic azoospermia), N46.11 (organic oligospermia), N46.021–N46.029 (azoospermia by specific etiology — e.g., N46.022 for azoospermia due to infection), N46.121–N46.129 (oligospermia by specific etiology). Supporting secondary codes: E28.2 (polycystic ovarian syndrome), N80.101–N80.9 (endometriosis by anatomical site), Z31.41 (encounter for fertility testing), Z31.84 (encounter for fertility preservation procedure — for fertility preservation encounters). For iatrogenic fertility preservation, list Z31.84 first (ICD-10-CM Official Guidelines, Section I.C.21.c.15, allow it only as the first-listed diagnosis) and the oncology diagnosis (e.g., C50.x for breast cancer) after it — never use N97.x for these patients.

Prior Authorization Requirements by Major Illinois Carrier

Prior authorization requirements for IVF and IUI under Illinois fully insured plans are set by each carrier and plan, and submission pathways differ by carrier. Routing a PA to the wrong entity results in no authorization being issued, which produces a denial at adjudication even when the service is clinically appropriate and mandate-compliant.

• BlueCross BlueShield of Illinois (BCBS IL) — BCBS IL's 2026 commercial prior authorization summary tells providers to check eligibility and benefits in the Availity Provider Portal to determine prior authorization requirements and the utilization management vendor, if any. That summary sends advanced imaging, cardiology, molecular genetic lab testing, musculoskeletal, radiation therapy and (ASO) sleep reviews to Carelon Medical Benefits Management (formerly AIM Specialty Health); infertility is not on the list, so do not assume fertility PA goes to Carelon. Confirm the authorization route at every initial eligibility call and re-verify annually, as carrier-vendor relationships change. At the same check, ask whether a frozen embryo transfer needs its own authorization or is covered by the retrieval authorization.
• Aetna Illinois — Aetna's Infertility Services Precertification Information Request Form (GR-69375-2) goes to Aetna's own Precertification Department, with questions routed to Aetna's Infertility Department; Aetna prefers electronic requests through its Availity provider portal and asks for the form at least 15 days before the planned treatment start. Aetna requires documentation of the infertility diagnosis and etiology, duration of infertility, prior treatment history, and the physician's treatment plan. The form lists IVF, ICSI, assisted hatching, frozen embryo transfer, PGT-A and PGT-M/PGT-SR as separate requested services, and Aetna reviews requests against Clinical Policy Bulletins 0327 (Infertility) and 0358. CPB 0327 requires a documented trial of egg-sperm contact before ART (for example, 4 cycles of timed intrauterine or intracervical insemination under age 35, or 3 cycles at 35 and older) and waives it for IVF when inseminations would not be expected to be effective — include the prior IUI records, or the treating physician's documentation of why insemination would not be effective. Aetna notes that prior treatment approval does not guarantee approval for ongoing or future treatment.
• UnitedHealthcare Illinois — UHC's commercial prior authorization requirements list infertility codes that require PA, including oocyte retrieval (58970), embryo transfer (58974) and embryology codes in the 89250–89291 range, and direct those requests to the Prior Authorization and Notification tool on the UnitedHealthcare Provider Portal. Optum Fertility Solutions is a separate clinical support and medical management program that some employer plans use; UHC states it also pays claims when the program is not used, so confirm at eligibility verification whether the member's plan sends fertility requests to Optum Fertility Solutions or to the UHC portal. UHC's fertility clinical criteria under Illinois mandate plans include documented infertility meeting the statutory definition, clinical indication for the proposed service, and physician treatment plan. UHC may apply its national fertility medical policy or a modified policy specific to the Illinois mandate product — obtain the applicable clinical criteria document from your provider relations contact.
• Cigna Illinois — Cigna Medical Coverage Policy 0089 (Infertility Services) lists IVF and ICSI among covered treatment services where the plan has an infertility benefit, and its coverage criteria do not set an IUI cycle count as a prerequisite for IVF. The policy also says delegated vendor guidelines may be used in certain markets, so confirm with Cigna at eligibility verification where fertility requests for the member's product are submitted and which services (FET, PGT) need their own request. If a reviewer asks for prior IUI cycles, ask which plan provision or policy criterion it is applying, and document any clinical contraindication to IUI in the request.
• Humana — In February 2023 Humana announced its exit from its Employer Group Commercial Medical Products business, and its FY2025 Form 10-K reports that the exit, covering all fully insured, self-funded and Federal Employee Health Benefit medical plans, was finalized during 2025. If a patient presents a Humana card for fertility services, verify what the coverage actually is (for example a Medicare Advantage plan) before treating it as an Illinois-mandate employer plan.

FET Billing Under Illinois Mandate Plans

FET billing is a frequent source of claim denials under Illinois mandate plans because many billing teams apply the IVF retrieval authorization number to FET claims — this generates a clinical inconsistency denial at adjudication. The FET CPT codes (89352 for embryo thaw; 58974 for embryo transfer) fall outside the scope of a retrieval authorization. Every FET cycle requires its own standalone prior authorization, submitted and approved before the FET monitoring begins.

Subsection (b) counts completed oocyte retrievals, not transfers, and applies only to policies issued or renewed before January 1, 2026. How a carrier records FET cycles against its own benefit tracking is carrier-specific and must be confirmed in writing. Aetna Illinois plans may apply a combined cycle limit that includes both retrievals and FETs. UHC and Cigna plans vary by specific plan document. When a patient transfers from another clinic with frozen embryos, obtain the prior clinic's cycle history documentation and confirm with the current insurer whether those FETs have been reported against the patient's lifetime benefit.

For practices billing embryo storage fees, neither 215 ILCS 5/356m nor the fertility preservation section (§356z.32) mentions embryo storage, so the statute neither requires nor excludes annual storage charges and coverage comes from the plan document. Confirm storage coverage at initial eligibility verification and communicate the patient's financial responsibility in writing before the embryos are frozen.

Common Illinois Mandate Billing Errors and Prevention

• Treating self-funded plans as mandate-compliant: The Illinois mandate does not apply to ERISA self-funded plans. Claims submitted as mandate-required to a self-funded plan that has not elected fertility coverage produce uncollectible write-offs. Prevention: confirm plan funding type in writing at every initial eligibility call and document it in the patient's billing record before treatment begins.
• Routing BCBS IL fertility PA to the wrong entity: a PA submitted through a pathway that does not manage the member's benefit leaves no authorization on record and results in a no-PA denial at adjudication. Prevention: confirm the PA route and any utilization management vendor through the Availity eligibility and benefits check for each BCBS IL patient, and re-check carrier-to-vendor routing at least annually.
• Applying the IVF retrieval authorization to FET claims: FET claims billed under the retrieval auth number are denied for clinical inconsistency. The FET CPT codes are not within scope of a retrieval authorization. Prevention: create a mandatory FET authorization trigger in your cycle management workflow that activates when a freeze-all cycle completes, when PGT results return, or when a fresh transfer is cancelled.
• Submitting PGT biopsy codes without PGT-specific prior authorization: Most Illinois carriers require separate PA for PGT (89290, 89291) distinct from the IVF retrieval authorization. Billing these codes under the IVF retrieval auth generates a denial. Prevention: build PGT PA as a discrete workflow step whenever PGT is planned, and confirm the PGT auth number is separate from the retrieval auth before submitting biopsy claims.
• Using infertility diagnosis codes for iatrogenic fertility preservation: Applying N97.x to an oncology patient's pre-chemotherapy egg freeze triggers medical necessity review under infertility criteria, which the patient does not meet. The claim denies. Prevention: use Z31.84 first-listed with the oncology diagnosis after it for all iatrogenic preservation claims and never apply infertility codes to this patient population.
• Logging cancelled stimulation cycles as consumed retrievals: Incorrectly recording a stimulation-only cycle with no egg retrieval as a lifetime cap cycle tells the patient they have fewer remaining benefits than they actually do and may result in collecting an out-of-pocket payment that should be billed to insurance. Prevention: define "completed retrieval" in your cycle tracking system to require an egg retrieval procedure date and confirm each carrier's counting definition in writing.
• Missing infertility-definition documentation for same-sex or single patient PA submissions: 215 ILCS 5/356m(c) lets these patients qualify under prong (2), inability to reproduce as a single individual or with a partner without medical intervention, or prong (3), a licensed physician's findings. A PA package that does not say which prong applies, or lacks the chart documentation behind it, invites a records request that delays the authorization and can push the cycle start date. Prevention: add a same-sex/single patient intake step that records the qualifying prong and collects the physician's supporting documentation before the PA submission date. Attach prior insemination records when the plan asks for them or, on pre-2026 policies, to show less costly treatment under subsection (b)(1).

Appealing Illinois Mandate Denials

Fully insured Illinois health plans are subject to robust appeal rights under the Illinois Insurance Code and the ACA. After exhausting the plan's internal appeal process, patients and providers may request external independent review through the Illinois Department of Insurance. External review decisions are binding on fully insured Illinois insurers. Self-funded plans are not subject to Illinois external review — ERISA plans have their own limited internal appeal and federal external review rights.

For Illinois mandate medical necessity denials, the appeal package should include: the complete infertility workup documentation establishing the diagnosis and etiology; confirmation that the patient meets the Illinois statutory infertility definition (for same-sex or single patients, the 356m(c)(2) or (c)(3) prong relied on and the physician's supporting documentation); prior treatment history relevant to the proposed service; the treating REI physician's signed letter of medical necessity; applicable ASRM Practice Committee Opinion guidelines; peer-reviewed literature supporting the proposed treatment for the patient's specific clinical presentation; and the plan's own fertility clinical criteria with a written argument identifying where those criteria conflict with 215 ILCS 5/356m. When a carrier (most commonly Cigna) applies a mandatory IUI cycle requirement prior to IVF for a patient with a documented contraindication to IUI, the appeal should explicitly cite the mandate's requirement to cover medically necessary IVF and the clinical basis for bypassing IUI cycles.

Request a peer-to-peer review with the plan's medical director for time-sensitive denials. Submit the P2P request within 48 hours of the denial notice when a cycle cannot be delayed. Where a utilization management vendor issued the denial, the P2P is with that vendor's physician reviewer, so request it through the entity named on the denial notice. Document the outcome of the verbal P2P in writing immediately after the call and follow up if written authorization is not issued within 24 hours.

Quarterly Billing Audit Checklist for Illinois Practices

A structured quarterly audit of Illinois mandate billing should verify: every IVF, FET, and PGT claim has a matching authorization number in the billing system before submission; BCBS IL fertility PA was submitted through the route confirmed at eligibility; plan funding type (fully insured vs. self-funded) is documented at the patient level and visible in the billing workflow before any cycle services are rendered; the policy issue or renewal date is recorded so the correct subsection applies; for pre-2026 policies, lifetime retrieval cycle counts are accurate, updated after each retrieval procedure, and confirmed against carrier-held records at the start of each new patient relationship; same-sex and single patient files record the 356m(c) prong the patient qualifies under, with the physician's supporting documentation, before the first PA submission; FET authorizations are standalone and not linked to the associated IVF retrieval authorization number; and all denial-to-appeal turnaround times are within the plan-specific internal appeal deadline (typically 180 days from denial) and ACA external review eligibility windows.